Human Galectin-3 Platinum ELISA

Description: The human Galectin-3 ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human Galectin-3. The human Galectin-3 ELISA is for in vitro diagnostic use. Not for use in therapeutic procedures.

Galectin-3 is a 26kDa -galactoside-binding protein belonging to the Galectin family, which consists of more than ten members. Galectin-3 is composed of a carboxyl-terminal carbohydrate recognition domain (CRD) and amino-terminal tandem repeats. Galectin-3 normally distributes in epithelia of many organs and various inflammatory cells, including macrophages as well as dendritic cells and Kupfer cells. The expression of this lectin is up-regulated during inflammation, cell proliferation and cell differentiation and through transactivation by viral proteins. Galectin-3 has been shown to function through both intracellular and extracellular actions. It is a component of heterogeneous nuclear ribonuclear protein (hnRNP), a factor in pre-mRNA splicing and has been found to control cell cycle and prevent T-cell apoptosis through interaction with the Bcl-2 family members. On the other hand, this protein, which is secreted from monocytes/macrophages and epithelial cells has been demonstrated to function as an extracellular molecule in activating various types of cells such as monocytes/macrophages, mast cells, neutrophils and lymphocytes. Galectin-3 has been shown to mediate cell-cell and cell-extracellular matrix interactions and acts as a novel chemoattractant for monocytes and macrophages.

Citations: Kang,E.H.; Moon,K.C.; Lee,E.Y.; Lee,Y.J.; Lee,E.B.; Ahn,C.; Song,Y.W.. Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis. Lupus 2009;18:22-28. (Link)

Plavina,Tatiana; Hincapie,Marina; Wakshull,Eric; Subramanyam,Meena; Hancock,William S.. Increased Plasma Concentrations of Cytoskeletal and Ca2+-Binding Proteins and Their Peptides in Psoriasis Patients. Clinical Chemistry 2008;54:1805-1814. (Link)

van Kimmenade,Roland R.; Januzzi,James L.,Jr.; Ellinor,Patrick T.; Sharma,Umesh C.; Bakker,Jaap A.; Low,Adrian F.; Martinez,Abelardo; Crijns,Harry J.; MacRae,Calum A.; Menheere,Paul P.; Pinto,Yigal M.. Utility of Amino-Terminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure. Journal of the American College of Cardiology 2006;48:1217-1224. (Link)

Dumont,Patrick; Berton,Alix; Nagy,Nathalie; Sandras,Flavienne; Tinton,Sandrine; Demetter,Pieter; Mascart,Francoise; Allaoui,Abdelmounaaim; Decaestecker,Christine; Salmon,Isabelle. Expression of galectin-3 in the tumor immune response in colon cancer. Lab Invest 2008;88:896-906. (Link)

Vereecken,P.; Zouaoui Boudjeltia,K.; Debray,C.; Awada,A.; Legssyer,I.; Sales,F.; Petein,M.; Vanhaeverbeek,M.; Ghanem,G.; Heenen,M.. High serum galectin-3 in advanced melanoma: preliminary results. Clinical and Experimental Dermatology 2006;31:105-109. (Link)

Doverhag,Christina; Keller,Matthias; Karlsson,Anna; Hedtjarn,Maj; Nilsson,Ulf; Kapeller,Edith; Sarkozy,Gergely; Klimaschewski,Lars; Humpel,Christian; Hagberg,Henrik; Simbruner,Georg; Gressens,Pierre; Savman,Karin. Pharmacological and genetic inhibition of NADPH oxidase does not reduce brain damage in different models of perinatal brain injury in newborn mice. Neurobiology of Disease 2008;31:133-144. (Link)

Stitt,Alan W.; McGoldrick,Ciara; Rice-McCaldin,Aine; McCance,David R.; Glenn,Josephine V.; Hsu,Daniel K.; Liu,Fu Tong; Thorpe,Suzanne R.; Gardiner,Tom A.. Impaired Retinal Angiogenesis in Diabetes: Role of Advanced Glycation End Products and Galectin-3. Diabetes 2005;54:785-794. (Link)

Vereecken,Pierre; Heenen,Michel; Babar,Sajida; Van Baren,Nicolas. Is serum galectin-3 a potential predictor of the response to active specific immunotherapy in melanoma patients?. Journal of the European Academy of Dermatology and Venereology 2006;21:278-280. (Link)

References: Sano,H.; Hsu,D.K.; Yu,L.; Apgar,J.R.; Kuwabara,I.; Yamanaka,T.; Hirashima,M.; Liu,F.T.. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J.Immunol. 2000;165:2156-2164. (Link)

Cooper,D.N.; Barondes,S.H.. God must love galectins; he made so many of them. Glycobiology 1999;9:979-984. (Link)

Dagher,S.F.; Wang,J.L.; Patterson,R.J.. Identification of galectin-3 as a factor in pre-mRNA splicing. Proc.Natl.Acad.Sci.U.S.A 1995;92:1213-1217. (Link)

Flotte,T.J.; Springer,T.A.; Thorbecke,G.J.. Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets. Am.J.Pathol. 1983;111:112-124. (Link)

Lotz,M.M.; Andrews,C.W.,Jr.; Korzelius,C.A.; Lee,E.C.; Steele,G.D.,Jr.; Clarke,A.; Mercurio,A.M.. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc.Natl.Acad.Sci.U.S.A 1993;90:3466-3470. (Link)

Liu,F.T.; Hsu,D.K.; Zuberi,R.I.; Kuwabara,I.; Chi,E.Y.; Henderson,W.R.,Jr.. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am.J.Pathol. 1995;147:1016-1028. (Link)

Bresalier,R.S.; Yan,P.S.; Byrd,J.C.; Lotan,R.; Raz,A.. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer 1997;80:776-787. (Link)

Nachtigal,M.; Al-Assaad,Z.; Mayer,E.P.; Kim,K.; Monsigny,M.. Galectin-3 expression in human atherosclerotic lesions. Am.J.Pathol. 1998;152:1199-1208. (Link)

Lindstedt,R.; Apodaca,G.; Barondes,S.H.; Mostov,K.E.; Leffler,H.. Apical secretion of a cytosolic protein by Madin-Darby canine kidney cells. Evidence for polarized release of an endogenous lectin by a nonclassical secretory pathway 79. J.Biol.Chem. 1993;268:11750-11757. (Link)

Fernandez,P.L.; Merino,M.J.; Gomez,M.; Campo,E.; Medina,T.; Castronovo,V.; Sanjuan,X.; Cardesa,A.; Liu,F.T.; Sobel,M.E.. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J.Pathol. 1997;181:80-86. (Link)

Agrwal,N.; Wang,J.L.; Voss,P.G.. Carbohydrate-binding protein 35. Levels of transcription and mRNA accumulation in quiescent and proliferating cells. J.Biol.Chem. 1989;264:17236-17242. (Link)

Nangia-Makker,P.; Ochieng,J.; Christman,J.K.; Raz,A.. Regulation of the expression of galactoside-binding lectin during human monocytic differentiation. Cancer Res. 1993;53:5033-5037. (Link)